Waltz Questions FDA's Telework Policies
February 02, 2024
February 02, 2024
WASHINGTON, Feb. 2 -- Rep. Michael Waltz, R-Florida, issued the following news release on Feb. 1, 2024:
On Wednesday, U.S. Congressman Mike Waltz (FL-06) sent a letter to Commissioner Robert Califf of the U.S. Food and Drug Administration (FDA) to question the telework policies at the FDA, which have minimized the operational standards for approving critical drugs and therapeutics.
"It has been four years since the pandemic hit our country yet a number of federal a . . .
On Wednesday, U.S. Congressman Mike Waltz (FL-06) sent a letter to Commissioner Robert Califf of the U.S. Food and Drug Administration (FDA) to question the telework policies at the FDA, which have minimized the operational standards for approving critical drugs and therapeutics.
"It has been four years since the pandemic hit our country yet a number of federal a . . .